"Avec une communauté de près de 16 000 professionnels, le CHU de Lille est l’un des plus grands campus santé du Nord de l’Europe. Hôpital universitaire de recours et de référence, d’enseignement, d’innovation et de recherche, il prend en charge des pathologies lourdes nécessitant un plateau médico-technique de pointe et une expertise médicale spécialisée. Près de 1.4 millions de patients y sont pris en charge chaque année, permettant au CHU de Lille de développer une expertise à la fois pour ses activités de recours et pour celles de proximité."

During the past decade, Hopital Claude Huriez; Hematologie conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Claude Huriez; Hematologie" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Celgene" with 8 trials sponsored, "Lymphoma Study Association" with 6 trials sponsored, "The Lymphoma Academic Research Organisation" with 3 trials sponsored and "University Hospital, Lille" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Claude Huriez; Hematologie" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Claude Huriez; Hematologie" are "Diffuse Large Cell Lymphoma" (4 trials), "Multiple Myeloma" (4 trials), "Myelodysplastic Syndromes" (4 trials), "Leukemia, Myeloid, Acute" (3 trials) and "Anemia" (2 trials). Many other conditions were trialed in "Hopital Claude Huriez; Hematologie" in a lesser frequency.

Most popular intervention types in "Hopital Claude Huriez; Hematologie" are "Drug" (37 trials), "Other" (4 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (8 trials), "Obinutuzumab" (7 trials), "Placebo" (7 trials), "Cyclophosphamide" (6 trials) and "Glofitamab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Claude Huriez; Hematologie" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Claude Huriez; Hematologie". undefined are not yet recruiting, 7 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Hopital Claude Huriez; Hematologie, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Claude Huriez; Hematologie, 11 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Hopital Claude Huriez; Hematologie has several departments that took part in Clinical trials: "CHU (Hôpital Calmette) - Pneumologie" - 11 trials, "Hopital Roger Salengro, Service de Neurologie" - 10 trials, "Hôpital Cardiologique" - 39 trials, "Hopital Claude Huriez; Medecine Interne Oncologie" - 5 trials, "Hopital Claude Huriez; Sce Dermatologie" - 5 trials, "Service de neuropédiatrie Pôle Pédiatrie CHRU de Lille - Hôpital Jeanne de Flandre" - 4 trials, "Service d'Anesthésie-Réanimation CCV Hôpital Cardiologique Centre Hospitalier et Universitaire de Lille" - 3 trials, "Unité médicale d'infectiologie, Hôpital Huriez, CHU de Lille" - 2 trials, "Intensive Care Department, Salengro Hospital,CHRU" - 2 trials, "CHRU Lille Service de Pneumologie et Oncologie Thoracique" - 2 trials, "Service d'Urologie CHRU de Lille, Hôpital HURIEZ" - 2 trials, "CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie" - 2 trials, "Pneumology department of CHU Lille" - 2 trials, "CHRU de LILLE - Hôpital Roger Salengro - Centre SLA-MMN - Sce de Neurologie et Pathologie du Mouvement" - 2 trials